IP Library Granted Patent US 9,925,149
Granted Patent B2
US 9,925,149 · App. 15/029,566 · Granted Mar 27, 2018

Nanoparticle compositions and methods as carriers of nutraceutical factors across cell membranes and biological barriers

Inventor: Richard Clark Kaufman (Santa Monica, CA)
Assignee: NANOSPHERE HEALTH SCIENCES, LLC
A61K9/5192A61K9/006A61K9/0014A61K9/0048A61K9/0053A61K9/127A61K9/1277A61K9/5123A61K31/047A61K31/05A61K31/07A61K31/122A61K31/185A61K31/198A61K31/202A61K31/23A61K31/352A61K31/353A61K31/355A61K31/375A61K31/385A61K31/4172A61K31/4415A61K31/675A61K31/685A61K31/7034A61K31/728A61K33/06A61K33/24A61K33/30A61K36/00A61K36/16A61K36/185A61K36/28A61K36/286A61K36/82A61K38/063
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,925,149
App. No.
15/029,566
Granted
Mar 27, 2018
Kind
B2
Abstract

Novel process and products thereby emplace nutraceutical factors within nanodelivery vehicles for various indications in mammals, including humans.

Claims (5)

1. A method for making improved lipid structural nanoparticle carrier systems comprising: combining essential phospholipids and fatty acids and solvents and using at least three production methods selected from the group consisting of high shear homogenization and ultrasonication, high pressure homogenization, microemulsions, solvent emulsification/evaporation, water-in-oil double, and milling utilizing cold techniques for formation of the lipid structural nanoparticles.

2. The method of claim 1 , wherein high pressure homogenization further comprises hot homogenization and cold homogenization.

3. The method of claim 1 further comprising adding at least one nutraceutical, effective for administration to mammals.

4. The method of claim 3 , further comprising adding at least an additional supplement, vitamin and related compound safe to administer to mammals.

5. The method of claim 1 wherein the nanoparticles are in the range of 20 to 60 nm.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 15, 2020
From: NANOSPHERE HEALTH SCIENCES, LLC
To: NANOSPHERE HEALTH SCIENCES INC.
Reel/Frame 054658/0852 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 19, 2016
From: KAUFMAN, RICHARD CLARK
To: NANOSPHERE HEALTH SCIENCES, LLC
Reel/Frame 038322/0094 →
Continuity (2)
Provisional Application 61890773 · Oct 14, 2013
Related Publication 20160263047A1 · Sep 15, 2016